Difficulty: Medium
Average Score: 72%
Practice
Regarding acute asthma exacerbations management, all of the following are false except:
Correct answer
B
Rationale
In the management of acute asthma exacerbations in pediatric patients, it is crucial to understand the appropriate pharmacological interventions to ensure optimal outcomes. Option B is the correct answer because it includes the standard and evidence-based treatment modalities for acute asthma exacerbations in children. Nebulized ╬▓2 agonists help in bronchodilation, systemic corticosteroids reduce airway inflammation, and ipratropium bromide acts as an additional bronchodilator.
Option A is incorrect because IV aminophylline is no longer recommended due to its narrow therapeutic window, potential for toxicity, and availability of safer alternatives like systemic corticosteroids. Option C is incorrect as formoterol, a long-acting ╬▓2 agonist, is not recommended for acute exacerbations, and methylxanthines like theophylline are used less frequently due to their side effect profile and narrow therapeutic window.
Option D is incorrect as salmeterol, a long-acting ╬▓2 agonist, is not indicated for acute exacerbations but rather for maintenance therapy. Including salmeterol and theophylline in the acute management regimen can lead to potential adverse effects without providing immediate relief.
Educationally, understanding the rationale behind each medication choice is essential for nurses caring for pediatric patients with asthma. This knowledge ensures safe and effective administration of medications, leading to improved patient outcomes. It is vital to stay updated with current guidelines to provide evidence-based care and prevent potential harm to patients.
Option A is incorrect because IV aminophylline is no longer recommended due to its narrow therapeutic window, potential for toxicity, and availability of safer alternatives like systemic corticosteroids. Option C is incorrect as formoterol, a long-acting ╬▓2 agonist, is not recommended for acute exacerbations, and methylxanthines like theophylline are used less frequently due to their side effect profile and narrow therapeutic window.
Option D is incorrect as salmeterol, a long-acting ╬▓2 agonist, is not indicated for acute exacerbations but rather for maintenance therapy. Including salmeterol and theophylline in the acute management regimen can lead to potential adverse effects without providing immediate relief.
Educationally, understanding the rationale behind each medication choice is essential for nurses caring for pediatric patients with asthma. This knowledge ensures safe and effective administration of medications, leading to improved patient outcomes. It is vital to stay updated with current guidelines to provide evidence-based care and prevent potential harm to patients.